growth-hormone
Low stock
Tesamorelin 5mg
$45.00
growth-hormone
CJC-1295 (No DAC) + Ipamorelin Blend 10mg
For in vitro research only
A growth-hormone-axis research blend combining 5 mg CJC-1295 (No DAC), a modified GRF(1-29) GHRH analog, with 5 mg Ipamorelin, a selective ghrelin-receptor agonist, supplied as a 10 mg total lyophilized vial for research into complementary growth-hormone secretagogue signaling.
Third-party testedView certificate
$102.94
Quantity
1
- Free shipping from $300
- Same-day shipping — order before 1 PM
- Secure payment
Promotion
Free 3 ml bacteriostatic water with every order.
Everything you need to start is included.
New
Advanced lab tests
HPLC tests
Endotoxin assay
TYMC test
TAMC test
Heavy metals screening
Technical specification
- Molecular formula
- -
- Molar mass
- -
- Purity
- ≥99%
- Synonyms
- CJC-1295 (No DAC) / Modified GRF(1-29) + Ipamorelin; 'CJC IPA'
- Solubility
- Water-soluble (reconstitute with bacteriostatic water)
- Organoleptic profile
- White to off-white lyophilized powder
- Composition
- Blend of two synthetic peptides — CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg — requires reconstitution
Key attributes
Kit contents
- 1 × CJC-1295 (No DAC) + Ipamorelin 10mg blend vial (5 mg + 5 mg)
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
Each vial is intended for laboratory research use only and is not for human or veterinary use.
Research usage
How is CJC-1295 (No DAC) + Ipamorelin Blend 10mg used in research?
This product combines two synthetic growth-hormone-secretagogue peptides in a single vial: CJC-1295 without DAC (Modified GRF(1-29)), a short-acting analog of growth-hormone-releasing hormone (GHRH), and Ipamorelin, a selective agonist of the ghrelin/growth-hormone-secretagogue receptor. In preclinical research models the two peptides are studied for their action on distinct but complementary pathways governing growth-hormone release — GHRH-receptor activation and ghrelin-receptor activation, respectively. Investigators examine such combinations to explore whether co-stimulation of both pathways produces additive or synergistic effects on pulsatile growth-hormone secretion in laboratory systems. Ipamorelin is frequently included in these studies for its reported selectivity, showing minimal influence on cortisol and prolactin in research models. The blend is used strictly as a reference tool in in-vitro and animal growth-hormone-axis research.
Research reports that GHRH analogs such as Modified GRF(1-29) and selective secretagogues such as Ipamorelin each stimulate growth-hormone release through their respective receptors in animal research models, and that co-administration of a GHRH analog with a ghrelin-receptor agonist has been associated with greater growth-hormone release than either peptide alone in preclinical studies. Investigators attribute this to the engagement of two complementary signaling pathways. Studies of Ipamorelin describe growth-hormone elevation with minimal accompanying changes in cortisol or prolactin, a selectivity of interest when interpreting combined-secretagogue data. Findings for the individual components remain confined to laboratory and animal research contexts, and results for any specific blend ratio are model-dependent.
The safety and toxicological profile of this peptide blend has not been characterized, and comprehensive data for the combination are not available. It should be handled only by qualified personnel using appropriate personal protective equipment and standard laboratory practices. This material is supplied strictly for in-vitro and preclinical research and is not for human or veterinary use. Avoid inhalation, ingestion, and contact with skin or eyes, and dispose of it in accordance with institutional guidelines.
Recommended ratio
- 2 mL of bacteriostatic water per 10 mg blend vial
- Equivalent to 5 mg/mL total (2.5 mg CJC-1295 + 2.5 mg Ipamorelin per mL; i.e. 0.5 mg total per 10 units on a 100 U insulin syringe)
- Disinfect the rubber stopper with an alcohol swab and allow it to dry.
- Inject the bacteriostatic water slowly down the inner wall of the vial rather than directly onto the powder.
- Swirl gently until fully dissolved (about 10 minutes); never shake.
Unopened / before reconstitution
Store refrigerated at 2-8°C, protected from light. Stable for approximately 24 months. For long-term storage, keep at -20°C.
Reconstituted solution
Keep refrigerated at 2-8°C and use within a few weeks. Avoid exposure to light and heat; do not repeatedly freeze and thaw.
Related research peptides.
See the protocol
growth-hormone
Low stock
CJC-1295 (No DAC) 5mg
$45.00
growth-hormone
Ipamorelin 5mg
$50.00
growth-hormone
AOD-9604 10mg
$85.78